The US Food and Drug Administration (FDA) has received a premarket tobacco product application (PMTA) from Canadian manufacturer TJP Labs for its L!X nicotine pouches. The company said its application to sell the pouches in the US is now moving on to the next step of the PMTA process.

TJP’s CEO David Richmond-Peck said the pouches were launched by its subsidiary L!X Innovations for adults who could not or chose not to quit nicotine but wished to drop cigarettes in favour of non-combustible, oral-use products.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us